1 Department of Psychiatry and Psychotherapy, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
2 Department of Medicine III, Institute for Clinical Immunology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
J Geriatr Psychiatry Neurol. 2019 Jul;32(4):211-220. doi: 10.1177/0891988719841728. Epub 2019 Apr 24.
Increased concentrations of interleukin 1 (IL-1) in the cerebrospinal fluid and serum of patients with Alzheimer disease (AD) reduced phagocytic capacity point to an inflammatory activation of mononuclear phagocytes in AD. Interleukin 1 receptors (IL-1R) and the macrophage scavenger receptor I (MSRI) are important players in IL-1 signaling and phagocytosis. In 20 patients with AD and 17 controls, IL-1RI, IL-1RII, and MSRI were assessed on peripheral blood mononuclear cells by flow cytometry. IL-1β, soluble IL-1 receptors, and IL-1R antagonist (IL-1Ra) were measured by enzyme-linked immunosorbent assay. The fraction of IL-1RI+ monocytes was increased by 10% and the expression of MSRI was reduced by 12% in AD. A 3.6% increased fraction of IL-1RI+ lymphocytes was accompanied by a 6.1% reduced expression of IL-1RII. The IL-1RI on monocytes and lymphocytes discriminated patients with AD with an accuracy of 0.79 and 0.75, respectively. The IL-1Ra was elevated in AD. Changes in the expression of IL-1 receptors and MSRI on peripheral blood cells fit to the concept of a proinflammatory state of the peripheral immune system. However, the observed differences are not strong enough to suggest their application as biomarkers for AD.
阿尔茨海默病(AD)患者脑脊液和血清中白细胞介素 1(IL-1)浓度升高,吞噬能力降低,表明 AD 中单核吞噬细胞发生炎症激活。白细胞介素 1 受体(IL-1R)和巨噬细胞清道夫受体 I(MSRI)是 IL-1 信号转导和吞噬作用的重要参与者。在 20 名 AD 患者和 17 名对照者中,通过流式细胞术评估外周血单个核细胞上的 IL-1RI、IL-1RII 和 MSRI。通过酶联免疫吸附试验测量 IL-1β、可溶性 IL-1 受体和 IL-1R 拮抗剂(IL-1Ra)。AD 中单核细胞的 IL-1RI+比例增加了 10%,MSRI 的表达降低了 12%。IL-1RI+淋巴细胞的比例增加了 3.6%,IL-1RII 的表达降低了 6.1%。单核细胞和淋巴细胞上的 IL-1RI 可分别以 0.79 和 0.75 的准确度区分 AD 患者。AD 中 IL-1Ra 升高。外周血细胞上 IL-1 受体和 MSRI 表达的变化符合外周免疫系统促炎状态的概念。然而,观察到的差异不够强,不足以表明它们可作为 AD 的生物标志物。